Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells. [electronic resource]
Producer: 20110131Description: 951-61 p. digitalISSN:- 1097-0215
- Adenoma -- drug therapy
- Adenomatous Polyposis Coli Protein -- physiology
- Animals
- Antineoplastic Agents -- pharmacology
- Blotting, Western
- CSK Tyrosine-Protein Kinase
- Cell Adhesion
- Cell Movement
- Cell Proliferation -- drug effects
- Cell Transformation, Neoplastic -- drug effects
- Cells, Cultured
- Colonic Neoplasms -- drug therapy
- Curcumin -- pharmacology
- Dasatinib
- Drug Synergism
- Electrophoretic Mobility Shift Assay
- Endothelium, Vascular -- cytology
- ErbB Receptors -- metabolism
- Female
- Humans
- Immunoenzyme Techniques
- Intestinal Neoplasms -- drug therapy
- Mice
- Mice, Knockout
- NF-kappa B -- genetics
- Neoplasm Invasiveness
- Neovascularization, Pathologic
- Protein Kinase Inhibitors -- pharmacology
- Protein-Tyrosine Kinases -- metabolism
- Pyrimidines -- pharmacology
- RNA, Messenger -- genetics
- Receptor, IGF Type 1 -- metabolism
- Reverse Transcriptase Polymerase Chain Reaction
- Thiazoles -- pharmacology
- Umbilical Veins -- cytology
- src-Family Kinases
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.